Immediate Impact

1 by Nobel laureates 2 from Science/Nature 90 standout
Sub-graph 1 of 20

Citing Papers

Empagliflozin in Patients with Chronic Kidney Disease
2022 Standout
Final Report of a Trial of Intensive versus Standard Blood-Pressure Control
2021 Standout
4 intermediate papers

Works of Mogensen Ce being referenced

Early ACE-i intervention in microalbuminuric patients with type 1 diabetes: effects on albumin excretion, 24 h ambulatory blood pressure, and renal function.
2001
ACE-inhibition and renoprotection in early diabetic nephropathy. Response to enalapril acutely and in long-term combination with conventional antihypertensive treatment.
1991
and 1 more

Author Peers

Author Last Decade Papers Cites
Mogensen Ce 166 121 76 217 168 30 593
Martin Egfjord 110 112 94 137 130 53 668
Danuta Fedak 84 96 105 102 138 43 599
Shan Lin 136 136 77 242 169 40 678
Feng Bai 138 91 67 97 217 31 586
Naoki Hase 140 231 59 89 200 24 553
B S Ooi 65 54 60 164 110 35 616
Britt Opdebeeck 72 66 70 287 183 18 547
J. Ruth Wu-Wong 69 51 63 254 104 28 660
Ana M. Blázquez‐Medela 53 102 64 104 272 24 676
Amal El‐Shehaby 56 41 100 126 178 24 674

All Works

Loading papers...

Rankless by CCL
2026